Camp4 Therapeutics (CAMP) Shares Issued (2023 - 2024)

Camp4 Therapeutics (CAMP) reported Shares Issued of $2.1 million for Q3 2024, down 8.57% sequentially from $2.3 million in Q4 2023.

Camp4 Therapeutics (CAMP) Shares Issued (2023 - 2024) Analysis & Trends

Camp4 Therapeutics (CAMP) has 2 years of Shares Issued data on file, last reported at $2.1 million in Q3 2024.

For the quarter ending Q3 2024, Shares Issued changed N/A year-over-year to $2.1 million; the trailing twelve-month figure through Sep 2024 stood at $2.1 million (changed N/A YoY), and the FY2023 full-year result was $2.3 million, changed N/A from the prior year.
Shares Issued declined to $2.1 million in Q3 2024, from $2.3 million in the prior quarter.
In the past five years, Shares Issued ranged from a high of $2.3 million in Q4 2023 to a low of $2.1 million in Q3 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Shares Issued (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-	-
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn	-
4	NuCana	279.75 Bn	279.75 Bn	-	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn	-
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn	-
7	Belite Bio	62.51 Bn	62.51 Bn	-	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn	-
9	Revolution Medicines	37.78 Bn	37.78 Bn	-	19.44 Mn
10	Camp4 Therapeutics	174.35 Mn	174.35 Mn	-	-

Download Data